Cardiovascular disease in persons with depressive and anxiety disorders.
about
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersDepression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: implications for cardiovascular riskCentral 5-HT1A receptor-mediated modulation of heart rate dynamics and its adjustment by conditioned and unconditioned fear in mice.Anxiety Disorders are Associated with Reduced Heart Rate Variability: A Meta-Analysis.Conflicts at work are associated with a higher risk of cardiovascular disease.Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic reviewRandomised controlled trial of a 12 week yoga intervention on negative affective states, cardiovascular and cognitive function in post-cardiac rehabilitation patientsSleep duration, insomnia, and markers of systemic inflammation: results from the Netherlands Study of Depression and Anxiety (NESDA)Reduced heart rate variability in social anxiety disorder: associations with gender and symptom severityThe Association between Antidepressant Medications and Coronary Heart Disease in Brazil: A Cross-Sectional Analysis on the Brazilian Longitudinal Study of Adult Health (ELSA-Brazil).The association between mood and anxiety disorders, and coronary heart disease in Brazil: a cross-sectional analysis on the Brazilian longitudinal study of adult health (ELSA-Brasil)How do high glycemic load diets influence coronary heart disease?The mechanism by which moderate alcohol consumption influences coronary heart disease.A mouse model of high trait anxiety shows reduced heart rate variability that can be reversed by anxiolytic drug treatment.Somatic, but not cognitive-affective, symptoms are associated with reduced heart rate variability in individuals with dysphoriaThe effect of cognitive appraisal for stressors on the oral health-related QOL of dry mouth patientsDisturbances in Hypothalamic-Pituitary-Adrenal Axis and Immunological Activity Differentiating between Unipolar and Bipolar Depressive EpisodesAssociation of depressive disorders, depression characteristics and antidepressant medication with inflammation.Worry is associated with robust reductions in heart rate variability: a transdiagnostic study of anxiety psychopathologyHypermethylation of FOXP3 Promoter and Premature Aging of the Immune System in Female Patients with Panic Disorder?Presence of an interaction between smoking and being overweight increases risks of hypertension, diabetes, and cardiovascular disease in outpatients with mood disorders.Pilot Investigation of PTSD, Autonomic Reactivity, and Cardiovascular Health in Physically Healthy Combat Veterans.Increased mean platelet volume in patients with panic disorder.Physical Comorbidities in Depression Co-Occurring with Anxiety: A Cross Sectional Study in the Czech Primary Care System.Anxiety disorders and inflammation in a large adult cohortAssociation of depression and psychotropic medication on cardiac-related outcomes in a nationwide community-dwelling elderly population in TaiwanThe association between immune activation and manic symptoms in patients with a depressive disorder.Cytokine production capacity in depression and anxiety.A review of the affects of worry and generalized anxiety disorder upon cardiovascular health and coronary heart disease.Atypical depression and double depression predict new-onset cardiovascular disease in U.S. adults.The relationships of coping, negative thinking, life satisfaction, social support, and selected demographics with anxiety of young adult college students.Unipolar depression and the progression of coronary artery disease: toward an integrative model.Angina self-management plan and quality of life, anxiety and depression in post coronary angioplasty patients.Medical comorbidity in recurrent versus first-episode depressive patients.Presence of depressive symptoms in patients with a first episode of acute coronary syndrome.A history of comorbid depression and anxiety predicts new onset of heart disease.Does obesity along with major depression or anxiety lead to higher use of health care and costs? A 6-year follow-up study.Use of hypnotics and the risk of or mortality from heart disease: a meta-analysis of observational studies.Respiratory, metabolic and cardiac functions are altered by disinhibition of subregions of the medial prefrontal cortex.Utilization of Mental Health Care, Treatment Patterns, and Course of Psychosocial Functioning in Northern German Coronary Artery Disease Patients with Depressive and/or Anxiety Disorders.
P2860
Q27009995-862727A7-24B7-453D-8BD6-0A43466E924DQ28480785-4D6161D8-DD08-4FFE-AACA-C8C7C6D276E2Q30429534-BE2C866E-B431-4385-A5F6-C95CFF1855A9Q30583469-32263E96-6196-4D92-9940-54AADA72756AQ33607648-6D5D69A7-CD68-4493-AAAF-D4D9F9DD7B4DQ34221937-9C7E3CEC-B51E-44DB-9B4C-A113723A362BQ34446728-9FAD9F84-EF83-462F-9ED0-46C69C7EF2ADQ34603386-4B821B38-546F-43EB-A9EC-9A4F22786F3FQ34922924-EFE50E6F-BB6E-4F60-8C59-80E003DC24CEQ34999246-4B2BE8E2-B462-469B-97A5-5E8CEB691186Q35120650-6A6A2A0A-CFB9-4D10-917D-42952A15925DQ35177141-61B39A59-1A78-4E21-A123-8C0BCA89CB92Q35315854-7C363C41-8AE6-4F26-B57B-C874336E57DBQ35406578-6C99E9FB-65E7-460D-99A1-CE77723DFE2AQ35579645-D599AA39-A104-4689-9C06-FDE0BD5EC598Q35653198-C37C00F3-E216-4A4F-946C-6691B7AF6222Q35701966-26E715E1-B0C8-4846-A7C6-AEA00528937AQ35844355-B1C65277-2607-44AE-ADF7-77538CF5E799Q36038822-AB900F07-CEEA-43F9-A43B-F103BC89832CQ36064829-C61E59E9-0544-4DA1-B6F0-D36B520B1AEFQ36078546-EE65392F-7745-460B-9C70-7DA8072E4C03Q36126499-E190AC4C-54C7-43EC-8AAB-C9E4A4E5346BQ36176741-554221D3-86F9-49AD-9379-1D1C4FE76C73Q36403693-D5D7665A-FA6A-489E-9328-3F008223271FQ36809773-6C583A3E-462A-4A24-B9DB-5639091DDFD5Q37165076-5A508747-2E3C-4B9D-B8FB-C277E56D3CC1Q37281155-14834792-AAFC-4B7E-8413-772B03411D20Q37349852-DEC2BCEA-69FD-4772-AE64-FF8A8F451622Q38074489-55A5F8A6-9A1C-4795-ADF4-C7509459A575Q38713810-40434B7C-3226-43C6-9DAA-2373853E5239Q39011048-DF9C0977-6A4C-432A-B746-71EBC1583BC8Q39742031-6E0E68D7-0305-4E09-A200-24C9D835F9C2Q41239963-2B2E33B8-7F44-41F8-9ADF-50B5724F30B1Q44746502-7770852E-E4C1-4F26-A47B-0BE1E91288C8Q45736034-36457221-F3D1-40D2-8AEA-B82637A35387Q45784990-9271DE47-F6BB-445E-8DB9-22FAA10ECA2FQ47600362-F4E392B7-2D57-46A5-BE1A-2F6ADDB22F0DQ47692944-C66F3881-D1AE-4705-9AC1-4B78B6E20A81Q49022828-D2E790F0-6BAF-465C-BB8B-77F040F2F9B1Q53423508-624A6B4E-2F8C-4F0E-926A-2D793DC7262A
P2860
Cardiovascular disease in persons with depressive and anxiety disorders.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cardiovascular disease in persons with depressive and anxiety disorders.
@ast
Cardiovascular disease in persons with depressive and anxiety disorders.
@en
Cardiovascular disease in persons with depressive and anxiety disorders.
@nl
type
label
Cardiovascular disease in persons with depressive and anxiety disorders.
@ast
Cardiovascular disease in persons with depressive and anxiety disorders.
@en
Cardiovascular disease in persons with depressive and anxiety disorders.
@nl
prefLabel
Cardiovascular disease in persons with depressive and anxiety disorders.
@ast
Cardiovascular disease in persons with depressive and anxiety disorders.
@en
Cardiovascular disease in persons with depressive and anxiety disorders.
@nl
P2093
P2860
P1476
Cardiovascular disease in persons with depressive and anxiety disorders
@en
P2093
Aartjan T F Beekman
Adrie Seldenrijk
Brenda W J H Penninx
Nicole Vogelzangs
Peter de Jonge
P2860
P304
P356
10.1016/J.JAD.2010.02.112
P577
2010-03-12T00:00:00Z